Human medicines European public assessment report (EPAR): Duloxetine Mylan, duloxetine, Neuralgia;Diabetic Neuropathies;Depressive Disorder, Major;Anxiety Disorders, Date of authorisation: 19/06/2015, Revision: 18, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.